Clinical trials
Intestinal Diseases trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 4 |
| Menarini Group | 2 |
| Pfizer | 2 |
| AstraZeneca | 1 |
| Cardenal Herrera University | 1 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
| Maimónides Biomedical Research Institute of Córdoba | 1 |
| Medtronic - MITG | 1 |
| Shield Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Intestinal Diseases | 21 |
| Gastrointestinal Diseases | 11 |
| Digestive System Diseases | 8 |
| Colonic Diseases | 7 |
| Neoplasms | 7 |
| Digestive System Neoplasms | 6 |
| Gastrointestinal Neoplasms | 6 |
| Intestinal Neoplasms | 6 |
| Colonic Neoplasms | 5 |
| Neoplasms by Site | 5 |
Trials
Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.